All Entries in the "Dangerous Drugs" Category
Mylotarg (gemtuzumab ozogamicin): Market Withdrawal
Drug failed to demonstrate clinical benefit to patients enrolled in trials.
Tamiflu: Counterfeit Product Sold on Internet
Potentially harmful product represented as “Generic Tamiflu”- tests revealed product does not contain oseltamivir, but cloxacillin, an antibiotic.
Orlistat (marketed as Alli and Xenical): Labeling Change
Revised labeling to include cases of severe liver injury.
Hylenex recombinant (hyaluronidase human injection): Recall
Voluntary recall of all manufactured lots has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of vials during routine stability testing.
Arrow Brand Medicated Oil and Embrocation: Consumer Warning, Product Considered Toxic
Product contains substances which are poisonous when ingested or applied to large areas of the body.
Intravenous Medications Manufactured by Claris: Recall due to contamination of products
Products sold under the Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Reports of floating matter in intravenous bags of metronidazole and ondansetron. Foreign matter should not be present in a sterile injectable product.
PediaCare Children’s Products [Blacksmith Brand]: Recall of four products
The four products were manufactured at a plant cited by FDA for deficiencies in Good Manufacturing Practices. Posted 05/30/2010
GammaGard Liquid, Immune Globulin Intravenous (Human)
Market withdrawal due to an increased number of adverse event reports of allergic reactions associated with two lots.
Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label Change
Risk of overdosage or suicide for patients who are addiction-prone, taking tranquilizers or antidepressant drugs.
Benadryl Extra Strength Itch Stopping Gel: Packaging Changes to Reduce Use Errors
Reports of consumers ingesting the gel rather than using it topically, applied to the skin.
